Salvia GmbH is a venture capital firm that focuses on deep-tech and science startups, particularly those addressing global challenges such as climate change and resource scarcity. The firm's strategy involves investing in innovative companies at Seed, Series A, and Series B stages, primarily in the United States, Germany, and Finland, to create long-term, sustainable value.
50% of their portfolio is in Healthcare. Their most common stage is pre-seed (50% of deals).
Portfolio
2
Fund Size
$5B
Top Stage
Pre Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Mimi Hearing Technologies | Series B | $25M | Dec 2021 |
| QQC Design | Pre-Seed | — | — |
Top Co-Investors
Vsquared Ventures1 shared
Quantonation1 shared
Last updated: 16 April 2026